Clinical trial
Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children
NCT02556996 is registered in ClinicalTrials.gov with U.S. Army Medical Research and Development Command as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children
- Lead sponsor
- U.S. Army Medical Research and Development Command
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 1998
- Completion date
- April 30, 2002
- Enrollment
- 356 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.